81693-22-3

3'-SLN SODIUM SALT Neu5Ac2-α-3Gal1-β-4GlcNAc Sialylated triaose type 2 GVXWGQLSDZJHFY-KDAHYMKLSA-N 3'-α-Sialyl-N-acetyllactosamine 3'-α-Sialyl-N-acetyllactosamine ,98% α-neunac-(2→3)-β-d-gal-(1→4)-d-glcnac 3'-Sialyl-N-acetyllactosaMine (3'-SLN) 3'-SIALYL-N-ACETYLLACTOSAMINE SODIUM SALT 3'-Sialyl-N-acetyllactosamine sodium salt 3'-a-Sialyl-N-acetyllactosamine sodium salt ALPHA-NEUNAC-[2->3]-BETA-D-GAL-[1->4]-D-GLCNAC 3'-N-acetylneuraminyl-N-acetyll-*actosamine sodiu 3'-N-ACETYLNEURAMINYL-N-ACETYLL-ACTOSAMI NE SODIUM 3'-N-ACETYLNEURAMINYL-N-ACETYLLACTOSAMINE SODIUM SALT 3'-N-Acetylneuraminyl-N-acetyllactosamine sodium salt >=95% 3'-N-Acetylneuraminyl-N-acetyllactosamine sodium salt >=95% 3'-N-ACETYLNEURAMINYL-N-ACETYLLACTOSAMINE SODIUM SALT USP/EP/BP Sialylated triose type 2 (sLex precursor) (>90% NMR) Sodium salt Sialylated triose type 2 (sLex precursor) grafted on BSA Sodium salt Sialylated triose type 2 (sLex precursor) grafted on HSA Sodium salt Sialylated triose type 2 (sLex precursor) grafted on KLH Sodium salt Sialylated triose type 2 (sLex precursor) grafted on OVA Sodium salt Sialylated triose type 2 (sLex precursor) grafted on CRM197 Sodium salt 3μ-Sialyl-N-acetyllactosamine, 3μ-SLN, α-NeuNAc-(2-3)-β-D-Gal-(1-4)-D-GlcNAc D-Glucose, O-(N-acetyl-α-neuraminosyl)-(2→3)-O-β-D-galactopyranosyl-(1→4)-2-(acetylamino)-2-deoxy- (2R,4S,5R,6R)-5-acetamido-2-[(2S,3R,4S,5S,6R)-2-[(2R,3S,4R,5R)-6-acetamido-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid